Oryzon Reports Results for Quarter Ended September 30 Read more about Oryzon Reports Results for Quarter Ended September 30
Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the healthcare sector Read more about Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the healthcare sector
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer Read more about SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
ORYZON holds its 4th annual Solidarity Day Read more about ORYZON holds its 4th annual Solidarity Day
SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2 Read more about SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2
ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia Read more about ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia
Ona Therapeutics is named as one of Fierce Biotech’s “Fierce 15” Biotech Companies of 2020 Read more about Ona Therapeutics is named as one of Fierce Biotech’s “Fierce 15” Biotech Companies of 2020
FDA Grants Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma Read more about FDA Grants Rare Pediatric Disease Designation (RPDD) to volasertib for rhabdomyosarcoma
ORYZON presents efficacy and safety results of its CLEPSIDRA trial with iadademstat in ED-SCLC patients at ESMO-2020 Read more about ORYZON presents efficacy and safety results of its CLEPSIDRA trial with iadademstat in ED-SCLC patients at ESMO-2020
Oryzon to present at upcoming international conferences Read more about Oryzon to present at upcoming international conferences
